| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041941896 |
Resistant |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.005357634 |
Resistant |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034349982 |
Sensitive |
